Most Recent
Bayer has lost its battle to protect top-selling blood thinner Xarelto from generic competition, with the Full Court finding two patents for the drug are invalid.
Coles and Woolworths have hit back at the ACCC's claims they advertised “illusory” discounts, pointing the finger at inflation and higher supply costs.
INPEX has won a bid to cross-examine AkzoNobel's solicitors about discovery at the end of an 11-week trial over allegedly defective paint used on the $45 billion Ichthys natural gas project.
A cash-strapped Bruce Lehrmann has dodged a bid by Ten for $200,000 to pursue his appeal of a judgment that found he raped former colleague Brittany Higgins.
An environmental group has lost a court challenge to controlled burns in the state’s Strathbogie Forest, despite arguing they would destroy the habitat of the endangered Southern greater glider.
A Melbourne couple has won their case over a “deliberately misleading” rendering of a $9.6 million South Yarra apartment.
Infant formula company Care A2 has found new lawyers as trial begins in a trade mark dispute with rival a2 Milk.
The High Court has been asked to take up an appeal by insurers over coverage for the class action defence costs of Opal Tower's consultant engineer.
A Sydney beautician has resolved her action seeking to set aside a bankruptcy notice filed by her alleged former lover, WiseTech Global boss Richard White.
Two firms representing some Rio Tinto shareholders have lost their bid to intervene in Energy Resources' fight to renew its lease for the Jabiluka uranium mine in the Northern Territory.